View in EDS

Safety and Efficacy of RAD001 (Everolimus) Administered Upon Relapse During or After Adjuvant Treatment in Post-menopausal Women With Hormone Receptor Positive, HER2/neu Negative Locally Advanced or Metastatic Breast Cancer (CRAD001JGR08 "MELPOMENI" study).

Saved in:
Bibliographic Details
Title: Safety and Efficacy of RAD001 (Everolimus) Administered Upon Relapse During or After Adjuvant Treatment in Post-menopausal Women With Hormone Receptor Positive, HER2/neu Negative Locally Advanced or Metastatic Breast Cancer (CRAD001JGR08 "MELPOMENI" study).
Authors: Alexopoulos A; 'HYGEIA' Hospital, Athens, Greece; a.alexo@yahoo.gr., Karanikiotis C; 'EUROMEDICA' General Clinic, Thessaloniki, Greece., Ardavanis A; 'Ag. Savvas' Regional Cancer Hospital, Athens, Greece., Boukovinas I; 'BIOKLINIKI' Hospital, Thessaloniki, Greece., Makrantonakis P; INTERBALKAN Medical Center, Thessaloniki, Greece., Papadimitriou C; 'IASO' General Hospital, Athens, Greece., Athanasiadis A; 'Koutlimbaneio and Triantafylleio' General Hospital, Larissa, Greece., Boutis A; 'THEAGENEIO' Anticancer Hospital, Thessaloniki, Greece., Giassas S; 'REA' Hospital, Athens, Greece., Kakolyris S; University General Hospital of Alexandroupolis, Alexandroupolis, Greece., Koumakis G; 'Ag. Savvas' Regional Cancer Hospital, Athens, Greece., Papazisis K; 'EUROMEDICA' General Clinic, Thessaloniki, Greece., Psyrri A; 'ATTIKO' University General Hospital, Athens, Greece., Ziras N; 'Metaxa' Anticancer Hospital of Piraeus, Piraeus, Greece., Baka S; INTERBALKAN Medical Center, Thessaloniki, Greece., Kentepozidis N; 251 Airforce General Hospital, Athens, Greece., Michalaki V; 'ARETAIEIO' Hospital, Athens, Greece.
Source: Anticancer research [Anticancer Res] 2022 Feb; Vol. 42 (2), pp. 1031-1041.
Publication Type: Journal Article; Observational Study
Journal Info: Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8102988 Publication Model: Print Cited Medium: Internet ISSN: 1791-7530 (Electronic) Linking ISSN: 02507005 NLM ISO Abbreviation: Anticancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1791-7530
DOI:10.21873/anticanres.15564